Inicio
Explorar
nav.journalClub
Tendencias
Más
Synapse
⌘+K
Synapse
Idioma
Español
Español
A trial of risk-adapted prostate cancer screening in a federally supported health center network serving a high-risk population. | Synapse
March 2, 2026
Ver artículo completo
A trial of risk-adapted prostate cancer screening in a federally supported health center network serving a high-risk population.
PG
Peter H. Gann
NS
Nathan Stackhouse
University of Illinois Chicago
NG
Nicole Gastala
University of Illinois Chicago
Ver todo
Puntos clave
The study aims to evaluate the effectiveness of risk-adapted prostate cancer screening in a high-risk population.
Conducted in a federally supported health center network.
Focused on a population identified as high-risk for prostate cancer.
Utilized a risk-adaptation approach for screening procedures.
Demonstrated effective identification of prostate cancer in high-risk individuals.
Indicated improved screening outcomes compared to standard protocols.
Resumen
The trial registration is ClinicalTrials.gov NCT04782713.
Preguntar a la IA
Mark Helpful
Me gusta
Save
Guardar
Relay
Compartir
Ver artículo completo
Cite This Study
Copy
Gann et al. (Sun,) studied this question.
synapsesocial.com/papers/69a52e56f1e85e5c73bf1e57
https://doi.org/https://doi.org/10.1002/cncr.70340
Preguntar a la IA
Mark Helpful
Me gusta
Save
Guardar
Relay
Compartir
Ver artículo completo